The abstract is read at the publisher; the summary is JClub's.
In UK, Japan, and the United States pandemic influenza planning models, antiviral stockpiles can still leave hospital surges 5–9× above staffed-bed capacity in severe events, even with 100% symptomatic treatment coverage.
- Why it matters: Legacy planning targets (e.g., 25% population coverage) emphasize cumulative burden but can miss healthcare system capacity limits during acute surges, risking crisis standards of care.
- What they did: The study projected daily hospital bed demand using a static lower-bound estimate, a deterministic transmission model, and mortality-based reconstructions of the 1918, 1957, and 1968 pandemics, then compared demand to national surge capacity (staffed beds) under best-case antiviral assumptions.
- The result: Stockpiles suppressed demand in moderate scenarios (analogous to 1957/1968) but were structurally insufficient in high-severity scenarios (analogous to 1918/CDC Very Severe), implying a capacity-based re-evaluation and motivating integrated, flexible mitigation until vaccines.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.